Peripheral/Endo

Artio Medical’s Amplifi™ Vein Dilation System Demonstrates Encouraging Clinical Results for Hemodialysis Patients Requiring Vascular Access

PRAIRIE VILLAGE, Kan., Nov. 30, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that full results from its first-in-human (FIH) clinical study of the Amplifi™ Vein Dilation System were presented at the 2021 VEITH Symposium by Surendra Shenoy, MD-PhD, […]

Soundbite Medical Announces Issuance Of A Fifth U.S. Patent Covering Novel Active Balloon Devices Intended For Plaque Modification Of Calcified Arteries

MONTREAL–(BUSINESS WIRE)–Soundbite Medical Solutions Inc. (SBMS), a medical device company dedicated to developing solutions for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced that the United States Patent and Trademark Office has issued US patent No. 11,179,169, entitled “Device for delivering mechanical waves through a balloon catheter”. […]

World’s First|Aopeng Medical Completes Clinical Trial of Robotic-Assisted Peripheral artery Intervention of iliac artery in human

SHANGHAI, Nov. 23, 2021 /PRNewswire/ — On November , 2021, Aopeng Medical’s ALLVAS™ Endovascular Intervention Surgical Robot, successfully completed the first-in-human clinical evaluation of robot-assisted peripheral artery intervention of iliac artery in the Department of Vascular Surgery at Shanghai Changhai Hospital. The procedure was operated by Prof. Qing-Sheng Lu and his colleagues. The endovascular […]

VentureMed Group Raises Convertible Note Along With Leadership Transition

MINNEAPOLIS, Nov. 23, 2021 /PRNewswire/ — VentureMed Group, Inc., a privately held medical device innovator in access management for arteriovenous (AV) fistulas and grafts and vessel preparation for interventional treatment of peripheral arterial disease (PAD) announced today that the company has raised a convertible note financing in addition to a transition in leadership. VentureMed […]

Endologix Announces Completion of Enrollment in the TORUS 2 Study for PAD in SFA

The TORUS 2 study is a prospective, single-arm trial of 188 patients to evaluate safety and effectiveness of the TORUS Stent Graft System in the treatment of PAD in the SFA and proximal popliteal arteries IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company dedicated to improving patients’ […]

Shockwave Medical Enrolls First Patient in Disrupt BTK II Study for Long, Calcified, Below the Knee Lesions

Global Post-Market Study Will Assess Long-Term Benefit of Peripheral IVL on the Most Challenging Calcified Lesions, Including Patients with Critical Limb Ischemia SANTA CLARA, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular […]

Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis

New indication expands addressable market for Pantheris REDWOOD CITY, CA / ACCESSWIRE / November 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that it has received 510(k) clearance […]

Calroy Health Sciences Awarded U.S. Patent for Vulnerable Plaque Stabilization and Regression

Arterosil® is a first-in-class product with an active patent for stabilization and regression of vulnerable plaque to support cardiovascular health SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Calroy Health Sciences, a company dedicated to developing innovative natural solutions to optimize cardiovascular health, has announced it has been awarded a patent titled “Methods to Stabilize and […]

Viz.ai Launches Two New AI-Powered Modules for Pulmonary Embolism and Aortic Disease

SAN FRANCISCO & ORLANDO, Fla.–(BUSINESS WIRE)–Viz.ai – the world leader in AI-driven intelligent care coordination, today announced the U.S. commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at the 48th annual VEITHsymposium November 16 – 20 in Orlando, Fla., the new modules allow for faster clinical decision making and improved […]

NEW RESEARCH FINDS CHALLENGES IN SYMPTOM RECOGNITION AND DIAGNOSTIC TESTING CAN IMPACT PATIENT SATISFACTION FOR PEOPLE WITH VASCULAR DISEASE

– One in four physicians surveyed feel the “lack of technology or equipment to make an accurate diagnosis of coronary artery disease and peripheral artery disease” is a key obstacle to an accurate diagnosis – Over a third of surveyed patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease […]